Page 7 - Inflarx Commitment Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inflarx commitment program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inflarx Commitment Program Today - Breaking & Trending Today

HC Wainwright Reaffirms Buy Rating for InflaRx (NASDAQ:IFRX)

HC Wainwright restated their buy rating on shares of InflaRx (NASDAQ:IFRX – Get Rating) in a research report sent to investors on Thursday morning, Benzinga reports. The brokerage currently has a $6.00 target price on the stock. InflaRx Stock Down 3.4 % Shares of IFRX stock opened at $1.80 on Thursday. The company has a […] ....

Niels Christoph Riedemann , Renfeng Guo , Nicolas Fulpius , Raymond James Financial Services Advisors Inc , Kestra Advisory Services , Raymond James Associates , Group One Trading , Jpmorgan Chase Co , Get Rating , James Financial Services Advisors , Advisory Services , Raymond James , Inflarx Daily , Nasdaq Ifrx , Reiterated Rating , Hc Wainwright ,

Germany's InflaRx, China's Staidson Surge After Agreeing on Covid-19 Drug Sales

Germany's InflaRx, China's Staidson Surge After Agreeing on Covid-19 Drug Sales
yicaiglobal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yicaiglobal.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Xiao Yi , Emmi Laine , Yicai Global , Staidson Beijing Biopharmaceuticals , Jena Based Inflarx , New Medicine , Bdb 001 , Profit Sharing Mechanism , Staidson Biopharma , Covid 19 ,

InflaRx (NASDAQ:IFRX) Short Interest Up 35.8% in May

InflaRx (NASDAQ:IFRX – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 130,900 shares, a growth of 35.8% from the May 15th total of 96,400 shares. Approximately 0.4% of the shares of the company are short sold. Based […] ....

United States , Raymond James , Geode Capital Management , Renaissance Technologies , Millennium Management , Commonwealth Equity Services , Get Rating , Equity Services , Sigma Investments , Nasdaq Ifrx ,

InflaRx (NASDAQ:IFRX) Stock Rating Upgraded by Zacks Investment Research

InflaRx (NASDAQ:IFRX – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Friday, Zacks.com reports. The brokerage currently has a $1.75 price objective on the stock. Zacks Investment Research‘s price target indicates a potential upside of 19.05% from the stock’s previous close. […] ....

United States , Raymond James , Geode Capital Management , Virtu Financial , Zacks Investment Research , De Shaw Co , Millennium Management , Get Rating , Investment Research , Capital Management , Two Sigma Investments , Nasdaq Ifrx ,

Zacks Investment Research Downgrades InflaRx (NASDAQ:IFRX) to Hold

InflaRx (NASDAQ:IFRX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “InflaRx N.V. is a clinical-stage biopharmaceutical company. It focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific […] ....

United States , Raymond James , Raymond James Financial Services Advisors Inc , Inflarx Company Profile Get Rating , Virtu Financial , Zacks Investment Research , Renaissance Technologies , Invesco Ltd , Get Rating , Montreal Can , Raymond James Financial Services Advisors , James Financial Services Advisors , Nasdaq Ifrx ,